10x Genomics, Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
10x Genomics, Inc. (TXG) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $50.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-08-07
- 10x Genomics, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-06-30 was $25.00M, a 50.00% decline year-over-year.
- 10x Genomics, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-03-31 was $25.00M.
- 10x Genomics, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-12-31 was $25.20M.
- 10x Genomics, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-30 was $50.00M.
- 10x Genomics, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $125.20M, a 385.61% increase from fiscal 2024.
- 10x Genomics, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $25.78M, a 68.87% decline from fiscal 2023.
- 10x Genomics, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $82.83M, a 347.03% increase from fiscal 2022.
- 10x Genomics, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $18.53M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $50.00M 10-Q · filed 2026-08-07 | $75.20M derived: sum of 3 quarters · filed 2026-08-07 | $125.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $25.00M 10-Q · filed 2026-05-08 | $50.20M derived: sum of 2 quarters · filed 2026-05-08 | $100.20M derived: sum of 3 quarters · filed 2026-05-08 | $150.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $25.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $75.20M derived: sum of 2 quarters · filed 2026-02-13 | $125.20M derived: sum of 3 quarters · filed 2026-08-07 | $125.20M 10-K · filed 2026-02-13 |
| 2025-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $100.00M derived: sum of 2 quarters · filed 2026-08-07 | $100.00M 10-Q · filed 2025-11-07 | $100.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $50.00M 10-Q · filed 2026-08-07 | $50.00M derived: sum of 3 quarters · filed 2026-08-07 | $50.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $12.81M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $12.81M derived: sum of 3 quarters · filed 2026-02-13 | $25.78M 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $12.81M derived: sum of 2 quarters · filed 2025-11-07 | $25.78M 10-Q · filed 2025-11-07 | $38.28M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $12.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $25.78M 10-Q · filed 2025-08-08 | $38.28M derived: sum of 3 quarters · filed 2026-02-13 | $57.42M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $12.97M 10-Q · filed 2025-05-09 | $25.47M derived: sum of 2 quarters · filed 2026-02-13 | $44.61M derived: sum of 3 quarters · filed 2026-02-13 | $63.90M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $12.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $31.64M derived: sum of 2 quarters · filed 2026-02-13 | $50.93M derived: sum of 3 quarters · filed 2026-02-13 | $82.83M 10-K · filed 2026-02-13 |
| 2023-09-30 | $19.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $38.44M derived: sum of 2 quarters · filed 2024-10-29 | $70.33M 10-Q · filed 2024-10-29 | $71.68M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $19.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $51.19M 10-Q · filed 2024-08-08 | $52.53M derived: sum of 3 quarters · filed 2025-02-13 | $60.59M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $31.90M 10-Q · filed 2024-04-30 | $33.24M derived: sum of 2 quarters · filed 2025-02-13 | $41.30M derived: sum of 3 quarters · filed 2025-02-13 | $50.17M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $9.40M derived: sum of 2 quarters · filed 2025-02-13 | $18.28M derived: sum of 3 quarters · filed 2025-02-13 | $18.53M 10-K · filed 2025-02-13 |
| 2022-09-30 | $8.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $16.93M derived: sum of 2 quarters · filed 2023-11-03 | $17.18M 10-Q · filed 2023-11-03 | $17.18M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $8.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $9.12M 10-Q · filed 2023-08-04 | $9.12M derived: sum of 3 quarters · filed 2024-02-15 | $9.12M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $250.00K 10-Q · filed 2023-05-04 | $250.00K derived: sum of 2 quarters · filed 2024-02-15 | $250.00K derived: sum of 3 quarters · filed 2024-02-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $0.00 derived: sum of 2 quarters · filed 2024-02-15 | $0.00 10-K · filed 2024-02-15 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-16 |